Phospholipase D: Regulation and Functional Significance
Advances in Pharmacology, ISSN: 1054-3589, Vol: 24, Issue: C, Page: 199-238
1993
- 29Citations
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations29
- Citation Indexes29
- 29
- CrossRef18
- Captures8
- Readers8
Article Description
This chapter discusses the evidence for the existence of receptor-coupled phospholipase D (PLD), together with recent information regarding its intracellular location, mode of activation, and functional role. PLD is a major route for hydrolysis of phosphatidylcholine in most tissues, consistent with it playing an important role in signal transduction. The enzyme appears to be activated by a variety of different mechanisms in different tissues, suggesting there might be several different isoforms. There is little direct evidence to indicate the functional significance of PLD activation but an accumulation of indirect evidence links PLD with prolonged changes in cell function. In particular, two areas where there is strong evidence for a role for PLD are mitogenesis and leukocyte hyperresponsiveness. An important area for future work can be the investigation of how products from the PLD pathway exert these effects. Current evidence suggests an important role for Ca 2+ -independent protein kinase C isoforms and probably also for novel cellular targets for the putative second messenger phosphatidic acid.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1054358908609382; http://dx.doi.org/10.1016/s1054-3589(08)60938-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0027357276&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/8389186; https://linkinghub.elsevier.com/retrieve/pii/S1054358908609382; http://linkinghub.elsevier.com/retrieve/pii/S1054358908609382; http://dx.doi.org/10.1016/s1054-3589%2808%2960938-2; https://dx.doi.org/10.1016/s1054-3589%2808%2960938-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know